메뉴 건너뛰기




Volumn 46, Issue 2, 2012, Pages 161-167

Preparation of glimepiride sustained release matrix tablets using Hibiscus rosa-sinensis leaves mucilage and povidone

Author keywords

Glimepiride; Hibiscus rosa sinensis; Matrix tablets; Povidone; Sustained release

Indexed keywords

GLIMEPIRIDE; POVIDONE;

EID: 84863539676     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (22)
  • 4
    • 33645038541 scopus 로고    scopus 로고
    • Development of sustained release low dose class II drug-Glimepiride
    • Jamzad S and Fassihi R. Development of sustained release low dose class II drug-Glimepiride, Int. J. Pharm. 2006; 312: 24-32.
    • (2006) Int. J. Pharm , vol.312 , pp. 24-32
    • Jamzad, S.1    Fassihi, R.2
  • 5
    • 79952581497 scopus 로고    scopus 로고
    • Fabrication and in vitro Evaluation of Glibendamide Abeimoschus escuientus Leaves Mucilage Sustained Release Matrix Tablets
    • Hindustan Abdul Ahad, Kishore Kumar Reddy B, Ishaq B Md, Hari Kumar C and Chitta Suresh Kumar. Fabrication and in vitro Evaluation of Glibendamide Abeimoschus escuientus Leaves Mucilage Sustained Release Matrix Tablets, Journal of Pharmacy Research, 2010; 3(5): 943-6.
    • (2010) Journal of Pharmacy Research , vol.3 , Issue.5 , pp. 943-946
    • Ahad, H.A.1    Kishore, K.R.B.2    Ishaq, B.3    Hari, K.C.4    Kumar, C.S.5
  • 6
    • 0002008594 scopus 로고
    • Examination of Natural Gums and Mucilages as Sustaining Agents in Tablet Dosage Forms
    • Baveja SK, Rao KV and Arora J. Examination of Natural Gums and Mucilages as Sustaining Agents in Tablet Dosage Forms, Indian J. Pharm. Sci. 1988; 50 (2): 89-92.
    • (1988) Indian J. Pharm. Sci , vol.50 , Issue.2 , pp. 89-92
    • Baveja, S.K.1    Rao, K.V.2    Arora, J.3
  • 7
    • 20644439328 scopus 로고    scopus 로고
    • Selection of excipients for extended release formulations of Glimepiride through drug-excipient compatibility testing
    • Verma, R. K. and Garg, S. Selection of excipients for extended release formulations of Glimepiride through drug-excipient compatibility testing, J. Pharma. Biomed. Ana, 2005; 38 (4); 633-44.
    • (2005) J. Pharma. Biomed. Ana , vol.38 , Issue.4 , pp. 633-644
    • Verma, R.K.1    Garg, S.2
  • 8
    • 67549105664 scopus 로고    scopus 로고
    • Preparation and In Vitro Evaluation of Sustained-Release Matrix Tablets of Flutamide Using Synthetic and Naturally Occurring Polymers
    • Jaber Emami, Mona Tajeddin and Fatemeh Ahmadi, Preparation and In Vitro Evaluation of Sustained-Release Matrix Tablets of Flutamide Using Synthetic and Naturally Occurring Polymers, Iranian Journal of Pharmaceutical Research, 2008; 7 (4): 247-57
    • (2008) Iranian Journal of Pharmaceutical Research , vol.7 , Issue.4 , pp. 247-257
    • Emami, J.1    Tajeddin, M.2    Ahmadi, F.3
  • 9
    • 0018867933 scopus 로고
    • Sustained release tablet formulation of propranolol hydrochloride with Eudragit
    • Jayaswa, SB, Gode KD and Khanna SK, Sustained release tablet formulation of propranolol hydrochloride with Eudragit. Aust. J. Pharm. Sci. 1980; 9:22-6
    • (1980) Aust. J. Pharm. Sci , vol.9 , pp. 22-26
    • Jayaswa, S.B.1    Gode, K.D.2    Khanna, S.K.3
  • 11
    • 79952011869 scopus 로고    scopus 로고
    • Formulation and evaluation of oral controlled release Glimepiride matrix tablets
    • Raparla, DV and Murthy, TE. Formulation and evaluation of oral controlled release Glimepiride matrix tablets. Adv. Phamacol. Toxical. 2007; 8(2): 59-62.
    • (2007) Adv. Phamacol. Toxical , vol.8 , Issue.2 , pp. 59-62
    • Raparla, D.V.1    Murthy, T.E.2
  • 12
    • 0001155833 scopus 로고    scopus 로고
    • Micro meritics
    • 4th ed. Philadelphia: Lippincott Williams & Wilkins
    • Martin A, Micro meritics. In: Physical Pharmacy. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001; p. 423-52.
    • (2001) Physical Pharmacy , pp. 423-452
    • Martin, A.1
  • 13
    • 84863541119 scopus 로고    scopus 로고
    • Pre-formulation: A need for dosage form design
    • RajeevGarg, pharmainfo
    • RajeevGarg. Pre-formulation: A need for dosage form design; pharmainfo. Net; 2008; 6.
    • (2008) Net , pp. 6
  • 15
  • 16
    • 84863547142 scopus 로고    scopus 로고
    • th Ed
    • th Ed. 2005; 1303-1304,2588-2589, A133.
    • (2005)
  • 17
    • 69749105164 scopus 로고    scopus 로고
    • Optimization of method for determination of swelling factor of Ispaghula husk seeds
    • Killedar SG, Bhagwat DA, Adnaik RS, More HN and D'souza JI. Optimization of method for determination of swelling factor of Ispaghula husk seeds, Indian Drugs, 2008; 45 (4): 310-3.
    • (2008) Indian Drugs , vol.45 , Issue.4 , pp. 310-313
    • Killedar, S.G.1    Bhagwat, D.A.2    Adnaik, R.S.3    More, H.N.4    D'souza, J.I.5
  • 18
    • 84863539982 scopus 로고
    • The United State of Pharmacopoeia 24/ NF19. Asian Edition, The official compendia of standard United States pharmacopoeial convection Inc. Rockville,
    • The United State of Pharmacopoeia 24/ NF19. Asian Edition, The official compendia of standard United States pharmacopoeial convection Inc. Rockville, 1995; 1015,1016, 1791.
    • (1995)
  • 21
    • 0344893332 scopus 로고
    • Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices
    • Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963; 52,1145-9.
    • (1963) J. Pharm. Sci , vol.52 , pp. 1145-1149
    • Higuchi, T.1
  • 22
    • 0026588498 scopus 로고
    • Accelerated stability of sustained release tablet prepared with Gelucire
    • Remunan C, Bretal M, Nunez A, Bila Jato JL. Accelerated stability of sustained release tablet prepared with Gelucire. Int J Pharm, 1992; 80:151-9.
    • (1992) Int J Pharm , vol.80 , pp. 151-159
    • Remunan, C.1    Bretal, M.2    Nunez, A.3    Bila, J.J.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.